Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Neuroblastoma 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 6Rituximab 6Radiotherapy 6Cyclophosphamide 6Antilymphocyte Serum 6Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Cyclosporine 5Whole-Body Irradiation 4Tacrolimus 4Methotrexate 4Flow Cytometry 4Etoposide 4Cord Blood Stem Cell Transplantation 4Busulfan 4tanespimycin 3romidepsin 3Melphalan 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Gemcitabine 3Bortezomib 3plerixafor 2nelarabine 2mogamulizumab 2cobomarsen 2carfilzomib 2belinostat 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mycosis Fungoides × Interleukin-12 Subunit p35 × Clear all
NCT00052377 2013-01-16

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

National Cancer Institute (NCI)

Phase 1/2 Terminated
46 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡